GWM
NBEV

Geneos Wealth Management’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Geneos Wealth Management’s Portfolio NBEV Stock Details NBEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,434
Closed -$3K – 3180
2021
Q1 		$3K Hold
1,434
– – ﹤0.01% 2848
2020
Q4 		$4K Buy
+1,434
New +$3.9K ﹤0.01% 2582

Other funds holding NBEV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geneos Wealth Management's NBEV Position: Q2 2021 in Review

Geneos Wealth Management sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q2 2021, closing a stake of 1,434 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in NBEV in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 99 funds tracked by Wall St. Rank hold NBEV as of Q2 2021.

  • Geneos Wealth Management reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1,434 NewAge, Inc. Common Stock (Delaware) shares in Q2 2021, an estimated $3K.
  • Geneos Wealth Management first reported a position in NewAge, Inc. Common Stock (Delaware) in Q4 2020 and held it in 2 quarters.
  • Geneos Wealth Management's NewAge, Inc. Common Stock (Delaware) position peaked at $4K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.